FIELD: chemistry.
SUBSTANCE: present invention relates to novel cannabidiol quinone derivatives of formula (I) or to their pharmaceutically acceptable salts
where R represents a carbon atom of a linear or branched group represented by an alkoxycarbonyl group; or wherein R represents a nitrogen atom of a linear or branched group represented by an alkylamino or benzylamine group used to treat diseases mediated by PPRAg, as well as to the composition containing the compounds of the invention.
EFFECT: new cannabidiol quinone derivatives are proposed.
8 cl, 15 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW CANNABYHEROLE DERIVATIVES | 2015 |
|
RU2684913C2 |
| HYDROXYPYRIDOXAZEPINES AS Nrf2 ACTIVATORS | 2020 |
|
RU2812931C2 |
| BENZOPIPERIDINE DERIVATIVES, BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1992 |
|
RU2142945C1 |
| THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE | 2005 |
|
RU2374250C2 |
| 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, METHOD FOR ITS OBTAINING AND ITS APPLICATION | 2019 |
|
RU2804127C2 |
| HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
| ARGINASE INHIBITORS AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2586219C2 |
| CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF | 2012 |
|
RU2586885C2 |
| ANALOGUES OF VITAMIN D, COMPOSITIONS CONTAINING INDICATED ANALOGUES AND THEIR USING | 2003 |
|
RU2320644C2 |
| TRITERPENE DERIVATIVES OF LUPEOL TYPE AS ANTIVIRAL PREPARATIONS | 2010 |
|
RU2561604C2 |
